Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
53.87
-0.40 (-0.74%)
Mar 6, 2026, 4:00 PM EST - Market closed
Supernus Pharmaceuticals Employees
Supernus Pharmaceuticals had 778 employees as of December 31, 2025. The number of employees increased by 104 or 15.43% compared to the previous year.
Employees
778
Change (1Y)
104
Growth (1Y)
15.43%
Revenue / Employee
$924,103
Profits / Employee
-$49,550
Market Cap
3.10B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Amneal Pharmaceuticals | 8,700 |
| Phibro Animal Health | 2,475 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| HUTCHMED (China) | 1,780 |
| Lantheus Holdings | 1,193 |
| ANI Pharmaceuticals | 970 |
SUPN News
- 10 days ago - Supernus Pharmaceuticals, Inc. (SUPN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 12 days ago - Supernus Pharmaceuticals to Participate in March Investor Conferences - GlobeNewsWire
- 23 days ago - Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026 - GlobeNewsWire
- 26 days ago - Lunai Bioworks, Inc. Issues Letter to Shareholders - PRNewsWire
- 4 weeks ago - Supernus: Outlook For 2026 Positive, Upholding Buy Rating - Seeking Alpha
- 7 weeks ago - These under-the-radar stocks combine fast growth with big upside potential - Market Watch
- 3 months ago - Supernus Pharmaceuticals, Inc. (SUPN) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript - Seeking Alpha